UNSPSC 51151632: Difemerine

This classification denotes an antimuscarinic agent with the molecular formula C20H25NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 843C4UPZ2F, chemically known as benzeneacetic acid, alpha-hydroxy-alpha-phenyl-, 2-(dimethylamino)-2-methylpropyl ester but generally known as difemerine, which bears US NIH Compound Identifier 165124. European Medicines Agency schedules Difemerine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07117MIG.

UNSPSC 51151632 Difemerine is a Commodity code that captures pharmaceutical products and medical supplies procured by state and local health authorities, though the recent solicitation activity under this code shows a significant scope mismatch—the posted opportunity concerns naloxone and drug deactivation systems rather than difemerine itself. Seminole County, Florida's IFB60459723LAS solicitation, posted June 30, 2026, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually to support community health initiatives. The county issued the IFB through its e-Procurement Portal with electronic bid submission required; vendors must provide unit costs, comply with drug-free workplace and E-Verify requirements, and maintain workers' compensation, commercial general liability, and professional liability insurance. The contract carries a two-year initial term with a one-year renewal option and includes a three-month probationary period permitting termination with or without cause. Potential FEMA funding introduces federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act, with contractors subject to audits and record inspections.

The sole recent opportunity on record places activity in Florida, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The July 26, 2023, response date in the record appears inconsistent with the June 30, 2026, posting date cited in the summary metadata, suggesting the opportunity may be archived or the dates contain errors. The issuing body is a county health authority rather than a state department or transit authority. Given the code assignment and the absence of difemerine-specific procurement signals in the available data, this code shows limited recent relevant activity for business development purposes; firms should verify current opportunities directly with Seminole County and other Florida health authorities to assess ongoing demand.